Cancer may be jamming life's last external audit -- and the Warburg effect may exist to fund it

Most cancer checkpoints (p53, Rb) are self-audits: they require the cell to honestly assess itself. Cancer disables them because a cell that's lost coherence can't honestly self-assess. But there's one checkpoint that doesn't require the cell's cooperation.

VDAC1 sits in the outer mitochondrial membrane and its oligomeric state -- whether it forms the death pore that releases cytochrome c -- is determined by membrane biophysics, not nuclear gene expression. The cholesterol-to-cardiolipin ratio, HK-II occupancy, and Bcl-xL binding combine into a threshold equation that the cell influences but doesn't fully control. It's the body's external audit of cellular fitness.

Using 5 independent AI models analyzing the same data without seeing each other's outputs (IRIS protocol), we mapped how cancer corrupts every term of this equation simultaneously:

- HK-II overexpressed → gate jammed by metabolic signal

- Bcl-xL/Bcl-2 overexpressed → extruded helices captured

- OMM cholesterol loaded → protective lattice stabilized

- All terms combined → apoptotic threshold pushed beyond any damage signal

The insight that stopped us: the Warburg effect (aerobic glycolysis) produces the glucose-6-phosphate that keeps HK-II loaded on VDAC1. The real product of cancer glycolysis may not be ATP but HK-II on the gate. The metabolic inefficiency IS the gate-jamming.

Testable prediction: glycolytic rate and apoptotic resistance should show a hyperbolic (not linear) relationship. Measurable by paired FDG-PET and caspase-activity assay.

Therapeutic implication: reactivating the gate requires simultaneously unjamming multiple terms. Metabolic (2-DG, DCA) + molecular (ABT-737, simvastatin) combinations should be supra-additive. The cofactor equation predicts CI < 0.8.

Full atlas: github.com/templetwo/vdac-pharmacology-atlas

Cancer is not a disease of growth. It is a disease of lost coherence -- a cell that forgot it's part of a body.